Versant Venture Capital VI, L.P.
SEC insider (Form 3/4/5 filer). CIK 0001687880. 10% Owner at LENZ Therapeutics, Inc. (LENZ) and 2 other issuers. 59 reported Form 4/5 transactions since Sep 2024; latest on Sep 30, 2025. Located in SAN FRANCISCO, CA.
Companies Versant Venture Capital VI, L.P. has filed insider reports for
- LENZ Therapeutics, Inc. (LENZ): 10% Owner
- LAVA Therapeutics NV (LVTX): 10% Owner
- Monte Rosa Therapeutics, Inc. (GLUE): 10% Owner
Versant Venture Capital VI, L.P.
CIK: 0001687880
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (59 total)
- Sep 30, 2025LENZ
LENZ Therapeutics, Inc.
SaleIndirect57.5K shares at avg. $46.41$2.7M - Sep 30, 2025LENZ
LENZ Therapeutics, Inc.
SaleDirect49.7K shares at avg. $45.35$2.3M - Sep 30, 2025LENZ
LENZ Therapeutics, Inc.
SaleDirect177 shares at avg. $47.01$8K - Sep 30, 2025LENZ
LENZ Therapeutics, Inc.
SaleIndirect34.4K shares at avg. $45.35$1.6M - Sep 30, 2025LENZ
LENZ Therapeutics, Inc.
SaleIndirect123 shares at avg. $47.01$6K - Sep 30, 2025LENZ
LENZ Therapeutics, Inc.
SaleDirect83.1K shares at avg. $46.41$3.9M - Sep 19, 2025LVTX
LAVA Therapeutics NV
SaleIndirect532.9K shares at avg. $1.40$747K - Sep 19, 2025LVTX
LAVA Therapeutics NV
SaleDirect2.4M shares at avg. $1.40$3.3M - Sep 18, 2025LENZ
LENZ Therapeutics, Inc.
SaleIndirect20.1K shares at avg. $43.00$866K - Sep 18, 2025LENZ
LENZ Therapeutics, Inc.
SaleDirect40.9K shares at avg. $43.00$1.8M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 30, 2025 |  LENZ LENZ Therapeutics, Inc. | Sale | 57,502 | $46.41 | $2,668,484 | Indirect |
| Sep 30, 2025 | LENZ LENZ Therapeutics, Inc. | Sale | 49,701 | $45.35 | $2,254,174 | Direct |
| Sep 30, 2025 | LENZ LENZ Therapeutics, Inc. | Sale | 177 | $47.01 | $8,321 | Direct |
| Sep 30, 2025 | LENZ LENZ Therapeutics, Inc. | Sale | 34,405 | $45.35 | $1,560,428 | Indirect |
| Sep 30, 2025 | LENZ LENZ Therapeutics, Inc. | Sale | 123 | $47.01 | $5,783 | Indirect |
| Sep 30, 2025 | LENZ LENZ Therapeutics, Inc. | Sale | 83,066 | $46.41 | $3,854,827 | Direct |
| Sep 19, 2025 |  LVTX LAVA Therapeutics NV | Sale | 532,870 | $1.40 | $746,764 | Indirect |
| Sep 19, 2025 | LVTX LAVA Therapeutics NV | Sale | 2,370,533 | $1.40 | $3,322,065 | Direct |
| Sep 18, 2025 | LENZ LENZ Therapeutics, Inc. | Sale | 20,148 | $43.00 | $866,441 | Indirect |
| Sep 18, 2025 | LENZ LENZ Therapeutics, Inc. | Sale | 40,907 | $43.00 | $1,759,156 | Direct |
1-10 of 59 transactions